Skip to main content
. 2022 Jul 18;111(11):1256–1268. doi: 10.1007/s00392-022-02056-5

Table 2.

Procedural characteristics

Procedural characteristics Treated patients (N = 72)
Procedural time (min), median [25th–75th percentile] 60.0 [50.0–75.0]
Amount of contrast used (mL), median [25th–75th percentile] 80.5 [61.3–140.0]
Unilateral procedure, n (%) 5 (6.9)
Renal denervation system
 Covidien OneSHOT™ (RF), n (%) 2 (2.8)
 Paradise (US), n (%) 14 (19.4)
 St. Jude EnligHTN (RF), n (%) 23 (31.9)
 Symplicity Flex™ (RF), n (%) 10 (13.9)
 Symplicity Spyral™ (RF), n (%) 19 (26.4)
 Vessix (RF), n (%) 4 (5.6)
Number of ablations LRA RRA
 Covidien OneSHOT™ (RF), median [25th–75th percentile] 1.0 [1.0–1.0] 1.0 [1.0–1.0]
 Paradise (US), median [25th–75th percentile] 3.0 [2.0–3.0] 3.0 [2.0–3.0]
  St. Jude EnligHTN (RF), median [25th–75th percentile] 8.0 [8.0–10.3] 8.0 [8.0–9.0]
 Symplicity Flex™ (RF), median [25th–75th percentile] 4.5 [4.0–5.8] 5.0 [5.0–6.0]
 Symplicity Spyral™ (RF), median [25th–75th percentile] 12.0 [10.0–15.5] 9.0 [6.0–12.0]
 Vessix (RF), median [25th–75th percentile] 4.0 [3.3–5.0] 4.5 [0.8–8.0]

US ultrasound, RF radiofrequency, LRA Left Renal Artery, RRA Right Renal Artery

*Unilateral procedure due to anatomical difficulties on the untreated side